Table 1 Correlation between expression of SEPT9 protein and clinicopathological parameters in breast cancer patients (n = 55)
Variables | SEPT9-Negative | SEPT9-Positive | γ, P | ||
|---|---|---|---|---|---|
No. of patients (n = 14) | % | No. of patients (n = 41) | % | ||
Age (years) | 0.011, 0.936 | ||||
≤45 | 5 | 36% | 18 | 44% | |
>45 | 9 | 64% | 23 | 56% | |
Tumor size (cm) | 0.191, 0.163 | ||||
≤2 | 5 | 36% | 16 | 39% | |
>2 | 9 | 64% | 25 | 61% | |
Metastatic lymph nodes | 0.367, 0.006** | ||||
Negative | 10 | 71% | 19 | 46% | |
Positive | 4 | 29% | 22 | 54% | |
Paxillin | 0.665, 0.000** | ||||
Negative | 11 | 79% | 11 | 27% | |
Positive | 3 | 21% | 30 | 73% | |
